SWASL
KMTS

Spartan Wealth Advisory Services LLC’s Kestra Medical Technologies KMTS Stock Holding History

Spartan Wealth Advisory Services LLC’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$786K Buy
30,886
+618
+2% +$12.9K 0.06% 177
2026
Q1 		$603K Buy
+30,268
New +$713K 0.05% 195

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Spartan Wealth Advisory Services LLC's KMTS Position: Q2 2026 in Review

Spartan Wealth Advisory Services LLC increased its Kestra Medical Technologies (KMTS) stake by 2% in Q2 2026, buying an estimated $12.9K and bringing the position to 30,886 shares worth $786K. The position accounts for 0.06% of the portfolio, ranked #177.

Spartan Wealth Advisory Services LLC first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Spartan Wealth Advisory Services LLC held 30,886 shares of Kestra Medical Technologies worth $786K as of Q2 2026.
  • Spartan Wealth Advisory Services LLC bought 618 Kestra Medical Technologies shares in Q2 2026, an estimated $12.9K.
  • Kestra Medical Technologies made up 0.06% of Spartan Wealth Advisory Services LLC's portfolio in Q2 2026, its #177 holding.
  • Spartan Wealth Advisory Services LLC first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Spartan Wealth Advisory Services LLC's 13F filing for Q2 2026, filed 5 Aug 2026.